Evaluation of the efficacy and tolerance of intravenously administered imipenem/cilastatin in the treatment of septicaemia

In an open study to determine the efficacy, safety and tolerance of intravenously administered imipenem/cilastatin (Tienam 500; Logos) in the treatment of septicaemia, 34 patients were given this thienamycin antibiotic in doses ranging from 1,5 g to 2 g daily for an average of 8,6 days (range 3 - 44...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	South African medical journal 1989-06, Vol.75 (11), p.529-531
1. Verfasser:	Linton, D.M., Aitchison, J.M. & Potgieter, P.D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Anaesthesiology Bacterial diseases Bacteriology Biological and medical sciences Cilastatin Cilastatin - administration & dosage Cilastatin - therapeutic use Clinical outcome Drug Combinations - therapeutic use Drug Evaluation Female Human bacterial diseases Humans Imipenem Imipenem - administration & dosage Imipenem - therapeutic use Infectious diseases Infusions, Intravenous Male Medical sciences Middle Aged Miscellaneous Multicenter Studies as Topic Pharmacology Sepsis - drug therapy Septicaemia Surgery Tropical medicine
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In an open study to determine the efficacy, safety and tolerance of intravenously administered imipenem/cilastatin (Tienam 500; Logos) in the treatment of septicaemia, 34 patients were given this thienamycin antibiotic in doses ranging from 1,5 g to 2 g daily for an average of 8,6 days (range 3 - 44 days).
ISSN:	0256-9574 2078-5135